BackReShape Lifesciences Overview

ReShape Lifesciences Inventory

Track ReShape Lifesciences's inventory ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00
↓ 100.00% YoYΔ $-2.53M vs prior year quarter

Peer average / median

Loading

ReShape Lifesciences Inventory History

Loading

ReShape Lifesciences vs. peers: Inventory Comparison

Loading

ReShape Lifesciences Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ReShape Lifesciences (RSLS) FAQ

ReShape Lifesciences (RSLS) currently reports a inventory of $0 as of March 2026. That compares with $2.5M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore ReShape Lifesciences's inventory history and peer comparisons.

ReShape Lifesciences's inventory decreased from $2.5M to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ReShape Lifesciences reported $0 in inventory as of March 2026. That compares with $2.5M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ReShape Lifesciences, and consider following RSLS for alerts when major investors trade the stock.

ReShape Lifesciences is classified in the Healthcare sector. On inventory, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RSLS with unrelated industries.